Kuhne v. Gossamer Bio, Inc.

District Court, S.D. California·Decided September 30, 2022·No. 3:20-cv-00649·Unknown

Opinion

UNITED STATES DISTRICT COURT

SCOTT KUHNE, individually and on Case No.: 3:20-cv-00649-DMS-DEB behalf of all others similarly situated, JUDGMENT APPROVING CLASS Plaintiff, ACTION SETTLEMENT v.

GIRAUDO, FAHEEM HASNAIN, JOSHUA H. BILENKER, M.D., COX, THOMAS DANIEL, M.D., RENEE GALA, OTELLO STAMPACCHIA, Ph.D., MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED, SVB CAPITAL INC., and EVERCORE GROUP L.L.C.,

Defendants.

WHEREAS, a class action is pending in this Court entitled Kuhne v. Gossamer Bio, Inc., et al., Case No. 3:20-cv-00649-DMS-DEB (the “Action”); WHEREAS, (a) Lead Plaintiff Scott Kuhne (“Lead Plaintiff”), on behalf of himself and the Class (defined below) and (b) Defendants Gossamer Bio, Inc. (“Gossamer” or “the Company”), Sheila Gujrathi, M.D., Bryan Giraudo, Faheem Hasnain, Joshua H. Bilenker, M.D., Kristina Burow, Russell Cox, Thomas Daniel, M.D., Renee Gala, Otello Stampacchia, Ph.D, Merrill Lynch, Pierce, Fenner & Smith Incorporated, SVB Leerink LLC, Barclays Capital Inc., and Evercore Group L.L.C. (the “Defendants”) (collectively with Lead Plaintiff, the “Settling Parties”) have determined to settle all claims asserted against Defendants in this Action with prejudice on the terms and conditions set forth in the Stipulation and Agreement of Class Action Settlement dated February 1, 2022 (the “Stipulation”) subject to approval of this Court (the “Settlement”); WHEREAS, unless otherwise defined in this Judgment, the capitalized terms herein shall have the same meaning as they have in the Stipulation; WHEREAS, by Order dated March 14, 2022 (the “Preliminary Approval Order”), this Court: (a) preliminarily approved the Settlement; (b) certified the Class solely for the purpose of effectuating the Settlement, finding the prerequisites for class action certification under Rule 23 of the Federal Rules of Civil Procedure with respect to the Settlement Class were satisfied; (c) ordered that notice of the proposed Settlement be provided to potential Class Members; (d) provided Class Members with the opportunity either to exclude themselves from the Class or to object to the proposed Settlement; (e) scheduled a hearing regarding final approval of the Settlement (“Settlement Hearing”) for June 24, 2022; and (f) postponed the Settlement Hearing to September 30, 2022; WHEREAS, due and adequate notice has been given to the Class; WHEREAS, the Court conducted the Settlement Hearing on September 30, 2022 to consider, among other things, (a) whether the terms and conditions of the Settlement are fair, reasonable and adequate to the Class, and should therefore be approved; and (b) whether a judgment should be entered dismissing the Action with prejudice as against the Defendants; WHEREAS, the Court having reviewed and considered the Stipulation, all papers filed and proceedings held herein in connection with the Settlement, all oral and written comments received regarding the Settlement, and the record in the Action; and WHEREAS, “when a settlement precedes class certification . . . , the district court must apply an even higher level of scrutiny[,]” McKinney-Drobnis v. Oreshack, 16 F.4th 594, 606 (9th Cir. 2021) (internal quotation omitted) and “This additional scrutiny requires the court to look for and scrutinize ‘any subtle signs that class counsel have allowed pursuit of their own self-interests to infect the negotiations[,]’” In Re Apple Inc. Device Performance Litigation, 2022 DJDAR 10250 (9th Cir., filed Sept. 28, 2022) (internal citations and quotations omitted); and WHEREAS, the Court has so scrutinized and finds good cause appearing therefor; IT IS HEREBY ORDERED, ADJUDGED AND DECREED: 1. Jurisdiction – The Court has jurisdiction over the subject matter of the Action, and all matters relating to the Settlement, as well as personal jurisdiction over all of the Settling Parties and each of the Class Members. 2. Incorporation of Settlement Documents – This Judgment incorporates and makes a part hereof: (a) the Stipulation filed with the Court on February 1, 2022; and (b) the Notice, the Summary Notice, and the Proof of Claim form, all of which were filed with the Court on February 2, 2022. 3. Certification of the Class for Purposes of Settlement – Pursuant to Rule 23 of the Federal Rules of Civil Procedure, this Court certifies, solely for purposes of effectuating the Settlement, this Action as a class action on behalf of the Class defined as: all Persons who purchased Gossamer common stock between February 8, 2019 and December 13, 2019, inclusive (the “Class Period”), and/or who acquired Gossamer shares pursuant or traceable to Gossamer’s Registration Statement and Prospectus in connection with the IPO. Excluded from the Class are Defendants and their families, the officers, directors, and affiliates, and their legal representatives, heirs, successors or assigns, and any entity in which Defendants have or had a controlling interest. The foregoing exclusion shall not cover Investment Vehicles. Also excluded from the Class are the Persons who timely and validly submitted a request for exclusion from the Class that was accepted by the Court; such Persons are listed on the attached Exhibit A. 4. Lead Plaintiff is hereby appointed, for purposes of effectuating the Settlement only, as representative for the Class for purposes of Federal Rule of Civil Procedure 23. Block & Leviton LLP, who was appointed by the Court to serve as Lead Counsel, is hereby appointed, for settlement purposes only, as counsel for the Class pursuant to Rules 23(c)(1)(B) and (g) of the Federal Rules of Civil Procedure. 5. Notice – The Court finds that the dissemination of the Notice, the online posting of the Notice, and the publication of the Summary Notice: (a) were implemented in accordance with the Preliminary Approval Order; (b) constituted the best notice practicable under the circumstances; (c) constituted notice that was reasonably calculated, under the circumstances, to apprise Class Members of (i) the pendency of the Action; (ii) the effect of the proposed Settlement (including the Releases to be provided thereunder); (iii) Lead Counsel’s motion for an award of attorneys’ fees and reimbursement of Litigation Expenses; (iv) their right to object to any aspect of the Settlement, the Plan of Allocation and/or Lead Counsel’s motion for attorneys’ fees and reimbursement of Litigation Expenses; (v) their right to exclude themselves from the Class; and (vi) their right to appear at the Settlement Hearing; (d) constituted due, adequate, and sufficient notice to all Persons entitled to receive notice of the proposed Settlement; and (e) satisfied the requirements of Rule 23 of the Federal Rules of Civil Procedure, the United States Constitution (including the Due Process Clause), the Private Securities Litigation Reform Act of 1995, 15 U.S.C. § 77z-1(a)(7), as amended, and all other applicable law and rules. 6. Final Settlement Approval and Dismissal of Claims – Pursuant to, and in acc

Free access — add to your briefcase to read the full text and ask questions with AI

Kuhne v. Gossamer Bio, Inc., (S.D. Cal. 2022).

Kuhne v. Gossamer Bio, Inc. (Kuhne v. Gossamer Bio, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related